Filing Flows › Biomerica (BMRA) › Q1 FY27
Biomerica (BMRA) Q1 FY27 earnings results (first quarter fiscal 2027)
10-Q filed Oct 15, 2026
Biomerica (BMRA) reported revenue of $1.3M for the first quarter fiscal 2027 (Q1 FY27), -8% from a year earlier and +45% from the quarter before. Operating margin was -97.0%, net loss $1.2M (97.4% of revenue).
Biomerica, Q1 FY27: revenue $1.3M (-8% year over year), operating margin -97.0%, net loss $1.2M, operating cash flow −$802K. The chart follows the revenue to costs, profit and cash.
| Q1 FY27 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3M | +45% | -8% |
| Operating profit | −$1.2M | — | — |
| Net earnings | −$1.2M | — | -61700% |
| Operating cash flow | −$802K | — | — |
What changed
Revenue was $1.3M in Q1 FY27, down 8% year over year and up 45% from the previous quarter. Clinical Lab was the largest line at 61% of revenue. Clinical Lab lost $249K year over year (down 24%), 217% of the total change.
Gross margin was 8.1%, down 22.6 points from Q1 FY26. Operating costs exceeded revenue by $1.2M, an operating margin of -97.0%. Operating expenses fell 14% while revenue fell 8%. The quarter ended with a net loss of $1.2M, wider than the previous quarter's $1.1M loss.
Operating cash flow was −$802K. Non-cash charges added back $15K of depreciation and amortization and $134K of share-based compensation. Working capital and other items added $281K.
Questions
What was Biomerica's revenue in the first quarter fiscal 2027?
Biomerica (BMRA) reported revenue of $1.3M for the first quarter fiscal 2027 (Q1 FY27), -8% from a year earlier and +45% from the quarter before.
Was Biomerica profitable in the first quarter fiscal 2027?
Operating loss was $1.2M (-97.0% of revenue) and net loss $1.2M.
Source: Biomerica 10-Q on SEC EDGAR.